KD can reduce seizure frequency and may improve cognition and behavior in TSC patients, playing an anti-epileptic role by inhibiting the over-activated mTOR signaling pathway and through other multi-target mechanisms involving neurotransmitters, brain energy metabolism, oxidative stress, and ion channels [84]. Here, MTOR is linked to tuberous sclerosis.